Loratadine And Pseudoephedrine Tablet, Extended Release
Product Images NDC 11822-9990

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Loratadine And Pseudoephedrine (NDC 11822-9990). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rite Aid, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (15 Tablet Blister Pack Carton)

The packaging label for Loratadine and Pseudoephedrine extended-release tablets, 10 mg Loratadine and 240 mg Pseudoephedrine Sulfate, distributed by Rite Aid. The label highlights allergy relief and nasal decongestant benefits, non-drowsy formula, 24-hour relief, and contains 15 tablets. The label also includes dosage form, active ingredients, drug facts panel, barcodes, and product NDC 11822-9990.*

FDA Label Image

Loratadine 02

Box label for Loratadine and Pseudoephedrine extended-release tablets, 10 mg loratadine and 240 mg pseudoephedrine sulfate per tablet, by Rite Aid. The label highlights 24-hour allergy relief and nasal decongestant effects, with 10 tablets in the package. It states the product is non-drowsy and intended for indoor/outdoor allergies. The label includes usage warnings, directions, drug facts, and a depiction of a white oval tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.